Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)

NCT01408056 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Difficulty with recruitment

Conditions

Infantile Hemangiomas

Interventions

DRUG: Timolol 0.5% Gel Forming Solution (GFS)
DRUG: Mupirocin 2% Ointment

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]